Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene

Nature Clinical Practice Endocrinology and Metabolism

Volumn 4, Issue 1, 2008, Pages 53-58

  Hannan, Fadil M ^a   Nesbit, M Andrew ^a   Christie, Paul T ^a   Fratter, Carl ^c   Dudley, Nicholas E ^d   Sadler, Greg P ^d   Thakker, Rajesh V ^b,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Endocrine neoplasia; Hypercalcemia; Parathyroid hormone

Indexed keywords

ASPARAGINE; CALCIUM; DNA; LEUCINE; PARATHYROID HORMONE; TRYPTOPHAN; TYROSINE;

ADULT; ALLELE; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FAMILIAL DISEASE; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; MALE; MISSENSE MUTATION; MULTIPLE ENDOCRINE NEOPLASIA GENE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID TUMOR; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; ALLELES; FEMALE; HUMANS; HYPERPARATHYROIDISM; LOSS OF HETEROZYGOSITY; MALE; MUTATION; PARATHYROIDECTOMY; PROTO-ONCOGENE PROTEINS;

EID: 37349016937     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0718     Document Type: Article

References (24)

1. Thakker RV (2006) Multiple Endocrine Neoplasia Type 1. In Endocrinology, 3509-3531 (Eds DeGroot LJ and Jameson JL) Philadelphia, PA: WB Saunders
2. Bradley KJ et al. (2005) Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J Intern Med 257: 18-26
3. Hoff AO and Gagel RF (2006) Multiple Endocrine Neoplasia Type 2. In Endocrinology, 3533-3550 (Eds DeGroot LJ and Jameson JL) Philadelphia, PA: WB Saunders
4. Adami S et al. (2002) Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17 (Suppl 2): N18-N23
5. Pannett AA et al. (2003) Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. Clin Endocrinol (Oxf) 58: 639-646
6. Patracchini P et al. (1989) Sublocalization of the human protein C gene on chromosome 2q13-q14. Hum Genet 81: 191-192
7. Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68: 820-823
8. Cetani F et al. (2004) Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89: 5583-5591
9. Simonds WF et al. (2004) Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89: 96-102
10. Villablanca A et al. (2004) Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). J Med Genet 41: e32
11. Bradley KJ et al. (2005) Utilisation of a cryptic noncanonical donor splice site of the gene encoding PARAFIBROMIN is associated with familial isolated primary hyperparathyroidism. J Med Genet 42: e51
12. Bradley KJ et al. (2006) Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clin Endocrinol (Oxf) 64: 299-306
13. Guarnieri V et al. (2006) Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance. J Clin Endocrinol Metab 91: 2827-2832
14. Kelly TG et al. (2006) Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Miner Res 21: 1666-1671
15. Mizusawa N et al. (2006) Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome. Clin Endocrinol (Oxf) 65: 9-16
16. Carpten JD et al. (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32: 676-680
17. Simonds WF et al. (2002) Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 81: 1-26
18. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75: 1297-1303
19. Thakker RV (2004) Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium 35: 275-282
20. Carling T et al. (2000) Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 85: 2042-2047
21. Warner J et al. (2004) Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J Med Genet 41: 155-160
22. Miedlich S et al. (2001) Familial isolated primary hyperparathyroidism-a multiple endocrine neoplasia type 1 variant? Eur J Endocrinol 145: 155-160
23. Brandi ML et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658-5671
24. Carneiro DM et al. (2002) Limited versus radical parathyroidectomy in familial isolated primary hyperparathyroidism. Surgery 132: 1050-1054